JuvoLab Announces Results of Study Analyzing Entire Global Oncology Community's Twitter Usage at ASCO 2010

First-ever aggregate analysis of physician, pharmaceutical and biotechnology industry, academic association, institution, journal, marketing and communications industry, non-profit organization, and patient advocate social media usage to discuss and disseminate breaking data and conduct compliant corporate promotion at the 2010 American Society of Clinical Oncology Annual Meeting (ASCO) released today

NEW YORK, July 15, 2010 - JuvoLab, a company focused on value creation in the life sciences
industry, today announced the release of a unique study detailing the entire
global oncology community's utilization of Twitter to enhance scientific
discussion at the ASCO 2010 Annual Meeting. This pioneering study analyzed
over 4450 tweets, generated by more than 680 users over the course of the
conference, and provides clarity and insight into the use of Twitter from
breaking clinical news and engaging in clinical discussion to compliant
corporate promotion by industry leaders. Users analyzed include medical
oncologists, comprehensive cancer centers, research institutions, academic
associations, leading pharmaceutical and biotechnology companies, non-profit
organizations, medical communications agencies, journals, journalists, and
patients and their advocates.

    The study demonstrates:

    - True extent of Twitter popularity among the ASCO 2010 constituent
      attendees
    - Functional role, demographics, and size of following for high-volume
      users who generated >75% of the total #ASCO10 content
    - Origin and contextual composition of tweets as clinical news, clinical
      discussion, promotional tweets, or other
    - Physicians as the highest generators of clinical discussion tweets and
      their aggregate views on key clinical management topics
    - Nature of discussions surrounding investigational or prescription drug
      products -- over 150 drugs or drug-drug combinations analyzed
    - Best practices in compliant pharmaceutical/biotechnology industry
      promotion via Twitter
    - Best practices in compliant academic association or institutional
      promotion via Twitter
    - Complexities and limitations in analyzing social media outputs

    This 49-page report is essential reading for all of the following:

    - Individuals and organizations looking to establish a credible and
      compliant social media presence at major medical meetings
    - Pharmaceutical and biotechnology industry marketing and corporate
      communications professionals
    - (Healthcare) social media experts
    - Public relations officers from academic associations, institutions,
      journals, and non-profit organizations

To order this report, Oncology Community Twitter Dialogue: ASCO 2010-Key
Insights in Compliant Healthcare Social Media Practice, please contact Aafia
Chaudhry, MD.

    E-mail aafia@juvolab.com
    Telephone +1-646-213-8173
    www.juvolab.com

Aafia Chaudhry, MD, +1-646-213-8173, aafia at juvolab.com